Ribomic Inc
TSE:4591
Ribomic Inc
Operating Expenses
Ribomic Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ribomic Inc
TSE:4591
|
Operating Expenses
-¥1.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Operating Expenses
-¥17.3B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-36%
|
|
PeptiDream Inc
TSE:4587
|
Operating Expenses
-¥10.4B
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Operating Expenses
-¥23.9B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Operating Expenses
-¥1.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
S
|
StemRIM Inc
TSE:4599
|
Operating Expenses
-¥2.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
See Also
What is Ribomic Inc's Operating Expenses?
Operating Expenses
-1.2B
JPY
Based on the financial report for Dec 31, 2023, Ribomic Inc's Operating Expenses amounts to -1.2B JPY.
What is Ribomic Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-2%
Over the last year, the Operating Expenses growth was 47%. The average annual Operating Expenses growth rates for Ribomic Inc have been 1% over the past three years , -2% over the past five years .